Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hui-Jen Tsai, MD
Taiwan Cooperative Oncology Group, National Health Research Institutes
Study Director - Tom Wei-Wu Chen, MD,PhD
National Taiwan University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Recruiting - Kaohsiung Medical University Chung-Ho Memorial Hospital,
Kaohsiung City, Taiwan
Recruiting - China Medical University Hospital
Taichung, Taiwan
Recruiting - National Cheng Kung University Hospital
Tainan, Taiwan
Recruiting - National Taiwan University Hospital
Taipei, Taiwan
Recruiting - Taipei Veterans General Hospital
Taipei, Taiwan
Recruiting - Tri-Service General Hospital
Taipei, Taiwan
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2025
- Primary completion
- 31 Jul 2028
- Completion
- 31 Jul 2029
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 81
- Registry id
- NCT06981637
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.